☰

Maria A. Croyle - Publications

Affiliations: 
University of Texas at Austin, Austin, Texas, U.S.A. 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bajrovic I, Schafer SC, Romanovicz DK, Croyle MA. Novel technology for storage and distribution of live vaccines and other biological medicines at ambient temperature. Science Advances. 6: eaau4819. PMID 32181330 DOI: 10.1126/Sciadv.Aau4819  0.352
2017 Jonsson-Schmunk K, Schafer SC, Croyle MA. Impact of nanomedicine on hepatic cytochrome P450 3A4 activity: things to consider during pre-clinical and clinical studies Journal of Pharmaceutical Investigation. 48: 113-134. DOI: 10.1007/S40005-017-0376-Y  0.443
2016 Jonsson-Schmunk K, Wonganan P, Choi JH, Callahan SM, Croyle MA. Integrin Receptors Play a Key Role in the Regulation of Hepatic Cytochrome P450 3A. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 26868618 DOI: 10.1124/Dmd.115.068874  0.763
2015 Jonsson-Schmunk K, Croyle MA. A long-lasting, single-dose nasal vaccine for Ebola: a practical armament for an outbreak with significant global impact. Expert Review of Anti-Infective Therapy. 13: 527-30. PMID 25796987 DOI: 10.1586/14787210.2015.1028368  0.325
2015 Choi JH, Schafer SC, Freiberg AN, Croyle MA. Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola Vaccine. Molecular Pharmaceutics. PMID 25549696 DOI: 10.1021/Mp5006454  0.413
2014 Choi JH, Jonsson-Schmunk K, Qiu X, Shedlock DJ, Strong J, Xu JX, Michie KL, Audet J, Fernando L, Myers MJ, Weiner D, Bajrovic I, Tran LQ, Wong G, Bello A, ... ... Croyle MA, et al. A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection. Molecular Pharmaceutics. PMID 25363619 DOI: 10.1021/Mp500646D  0.357
2014 Wonganan P, Jonsson-Schmunk K, Callahan SM, Choi JH, Croyle MA. Evaluation of the HC-04 cell line as an in vitro model for mechanistic assessment of changes in hepatic cytochrome P450 3A during adenovirus infection. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 1191-201. PMID 24764148 DOI: 10.1124/Dmd.113.056663  0.764
2013 Choi JH, Schafer SC, Zhang L, Juelich T, Freiberg AN, Croyle MA. Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine. Molecular Pharmaceutics. 10: 3342-55. PMID 23915419 DOI: 10.1021/Mp4001316  0.346
2013 Leggiero E, Astone D, Cerullo V, Lombardo B, Mazzaccara C, Labruna G, Sacchetti L, Salvatore F, Croyle M, Pastore L. PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice. Gene Therapy. 20: 1124-1130. PMID 23883962 DOI: 10.1038/Gt.2013.38  0.405
2013 Choi JH, Croyle MA. Emerging targets and novel approaches to Ebola virus prophylaxis and treatment. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 27: 565-83. PMID 23813435 DOI: 10.1007/S40259-013-0046-1  0.374
2013 Shedlock DJ, Aviles J, Talbott KT, Wong G, Wu SJ, Villarreal DO, Myles DJ, Croyle MA, Yan J, Kobinger GP, Weiner DB. Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1432-44. PMID 23670573 DOI: 10.1038/Mt.2013.61  0.327
2013 Leggiero E, Astone D, Cerullo V, Lombardo B, Mazzaccara C, Labruna G, Sacchetti L, Salvatore F, Croyle M, Pastore L. Erratum: PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice Gene Therapy. 20: 1192-1192. DOI: 10.1038/Gt.2013.45  0.349
2012 Choi JH, Schafer SC, Zhang L, Kobinger GP, Juelich T, Freiberg AN, Croyle MA. A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs. Molecular Pharmaceutics. 9: 156-67. PMID 22149096 DOI: 10.1021/Mp200392G  0.348
2012 Choi JH, Dekker J, Schafer SC, John J, Whitfill CE, Petty CS, Haddad EE, Croyle MA. Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity. Clinical and Vaccine Immunology : Cvi. 19: 84-95. PMID 22089246 DOI: 10.1128/Cvi.05319-11  0.379
2011 Wonganan P, Clemens CC, Brasky K, Pastore L, Croyle MA. Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus. Molecular Pharmaceutics. 8: 78-92. PMID 20822161 DOI: 10.1021/Mp100216H  0.467
2010 Wonganan P, Croyle MA. PEGylated Adenoviruses: From Mice to Monkeys. Viruses. 2: 468-502. PMID 21994645 DOI: 10.3390/V2020468  0.351
2010 Richardson JS, Dekker JD, Croyle MA, Kobinger GP. Recent advances in Ebolavirus vaccine development. Human Vaccines. 6: 439-49. PMID 20671437 DOI: 10.4161/Hv.6.6.11097  0.37
2010 Renteria SS, Clemens CC, Croyle MA. Development of a nasal adenovirus-based vaccine: Effect of concentration and formulation on adenovirus stability and infectious titer during actuation from two delivery devices. Vaccine. 28: 2137-48. PMID 20044048 DOI: 10.1016/J.Vaccine.2009.12.025  0.375
2009 Croyle MA. Long-term virus-induced alterations of CYP3A-mediated drug metabolism: a look at the virology, immunology and molecular biology of a multi-faceted problem. Expert Opinion On Drug Metabolism & Toxicology. 5: 1189-211. PMID 19732028 DOI: 10.1517/17425250903136748  0.498
2009 Richardson JS, Yao MK, Tran KN, Croyle MA, Strong JE, Feldmann H, Kobinger GP. Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine. Plos One. 4: e5308. PMID 19390586 DOI: 10.1371/Journal.Pone.0005308  0.452
2008 Wonganan P, Zamboni WC, Strychor S, Dekker JD, Croyle MA. Drug-virus interaction: effect of administration of recombinant adenoviruses on the pharmacokinetics of docetaxel in a rat model. Cancer Gene Therapy. 16: 405-14. PMID 19110543 DOI: 10.1038/Cgt.2008.99  0.515
2008 Croyle MA, Patel A, Tran KN, Gray M, Zhang Y, Strong JE, Feldmann H, Kobinger GP. Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice. Plos One. 3: e3548. PMID 18958172 DOI: 10.1371/Journal.Pone.0003548  0.358
2008 Callahan SM, Wonganan P, Croyle MA. Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection. Virology Journal. 5: 111. PMID 18826641 DOI: 10.1186/1743-422X-5-111  0.808
2008 Boquet MP, Wonganan P, Dekker JD, Croyle MA. Influence of method of systemic administration of adenovirus on virus-mediated toxicity: focus on mortality, virus distribution, and drug metabolism. Journal of Pharmacological and Toxicological Methods. 58: 222-32. PMID 18723098 DOI: 10.1016/J.Vascn.2008.07.003  0.494
2008 Callahan SM, Wonganan P, Obenauer-Kutner LJ, Sutjipto S, Dekker JD, Croyle MA. Controlled inactivation of recombinant viruses with vitamin B2. Journal of Virological Methods. 148: 132-45. PMID 18160141 DOI: 10.1016/J.Jviromet.2007.10.027  0.766
2008 Patel A, Zhang Y, Croyle M, Tran K, Gray M, Strong J, Feldmann H, Wilson JM, Kobinger GP. Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice. The Journal of Infectious Diseases. S413-20. PMID 17940978 DOI: 10.1086/520603  0.383
2006 Le HT, Boquet MP, Clark EA, Callahan SM, Croyle MA. Renal pathophysiology after systemic administration of recombinant adenovirus: changes in renal cytochromes P450 based on vector dose. Human Gene Therapy. 17: 1095-111. PMID 17069534 DOI: 10.1089/Hum.2006.17.1095  0.787
2006 Callahan SM, Boquet MP, Ming X, Brunner LJ, Croyle MA. Impact of transgene expression on drug metabolism following systemic adenoviral vector administration. The Journal of Gene Medicine. 8: 566-76. PMID 16508909 DOI: 10.1002/Jgm.884  0.801
2006 Croyle M, Feldmann H, Jones S, Wilson JM, Kobinger GP. 595. Nasal Delivery of Adenovirus Expressing the Ebola Glycoprotein Protects Mice Against Ebola Virus in the Presence of Preexisting Immunity to the Vaccine Carrier Molecular Therapy. 13: S230. DOI: 10.1016/J.Ymthe.2006.08.669  0.395
2005 Le HT, Yu QC, Wilson JM, Croyle MA. Utility of PEGylated recombinant adeno-associated viruses for gene transfer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 108: 161-77. PMID 16125817 DOI: 10.1016/J.Jconrel.2005.07.019  0.359
2005 Croyle MA, Le HT, Linse KD, Cerullo V, Toietta G, Beaudet A, Pastore L. PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile. Gene Therapy. 12: 579-87. PMID 15647765 DOI: 10.1038/Sj.Gt.3302441  0.465
2005 Callahan SM, Ming X, Lu SK, Brunner LJ, Croyle MA. Considerations for use of recombinant adenoviral vectors: dose effect on hepatic cytochromes P450. The Journal of Pharmacology and Experimental Therapeutics. 312: 492-501. PMID 15496614 DOI: 10.1124/Jpet.104.075374  0.797
2005 Callahan SM, Wonganan P, Obenauer-Kutner LJ, Sutjipto S, Le HT, Croyle MA. 414. Vitamin B2: A Key Component for Controlled Inactivation of Viruses Suitable for Biological Use Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.417  0.779
2005 Boquet MP, Le HT, Clark EA, Callahan SM, Croyle MA. 412. Renal Pathophysiology after Systemic Administration of a Recombinant Adenovirus: Changes in Drug Metabolism Based upon Vector Dose Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.415  0.8
2005 Le HT, Boquet MP, Clark EA, Callahan SM, Croyle MA. 148. The Transgene Cassette Is Not Fully Responsible for Alterations of Renal Cytochrome P450 Expression after Systemic Administration of Recombinant Adenovirus Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.152  0.789
2005 Callahan SM, Boquet MP, Wonganan P, Croyle MA. 142. Molecular and Macromolecular Alterations of Recombinant Adenoviral Vectors Do Not Eliminate Changes in Hepatic Drug Metabolism Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.147  0.806
2004 Croyle MA, Callahan SM, Auricchio A, Schumer G, Linse KD, Wilson JM, Brunner LJ, Kobinger GP. PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. Journal of Virology. 78: 912-21. PMID 14694122 DOI: 10.1128/Jvi.78.2.912-921.2004  0.768
2003 Cheng X, Ming X, Croyle MA. PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route. Pharmaceutical Research. 20: 1444-51. PMID 14567640 DOI: 10.1023/A:1025714412337  0.419
2002 Croyle MA, Chirmule N, Zhang Y, Wilson JM. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Human Gene Therapy. 13: 1887-900. PMID 12396620 DOI: 10.1089/104303402760372972  0.367
2001 Croyle MA, Cheng X, Sandhu A, Wilson JM. Development of novel formulations that enhance adenoviral-mediated gene expression in the lung in vitro and in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 4: 22-8. PMID 11472102 DOI: 10.1006/Mthe.2001.0411  0.389
2001 Zhang Y, Chirmule N, Gao GP, Qian R, Croyle MA, Joshi B, Tazelaar J, Wilson JM. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Molecular Therapy. 3: 697-707. PMID 11356075 DOI: 10.1006/Mthe.2001.0329  0.322
2001 Croyle MA, Chirmule N, Zhang Y, Wilson JM. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. Journal of Virology. 75: 4792-801. PMID 11312351 DOI: 10.1128/Jvi.75.10.4792-4801.2001  0.414
2000 Croyle MA, Yu QC, Wilson JM. Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions. Human Gene Therapy. 11: 1713-22. PMID 10954905 DOI: 10.1089/10430340050111368  0.404
1998 Croyle MA, Stone M, Amidon GL, Roessler BJ. In vitro and in vivo asessment of adenovirus 41 as a vector for gene delivery to the intestine Gene Therapy. 5: 645-654. PMID 9797869 DOI: 10.1038/Sj.Gt.3300645  0.43
1998 Croyle MA, Anderson DJ, Roessler BJ, Amidon GL. Development of a highly efficient purification process for recombinant adenoviral vectors for oral gene delivery. Pharmaceutical Development and Technology. 3: 365-72. PMID 9742557 DOI: 10.3109/10837459809009864  0.329
Show low-probability matches.